Can Biology Trump Anatomy? Do All Node-Positive Patients With Breast Cancer Need Chemotherapy?
- 20 June 2007
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (18) , 2501-2503
- https://doi.org/10.1200/jco.2007.11.3290
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast CancerJAMA, 2006
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerNew England Journal of Medicine, 2005
- Breast Cancer Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Adjuvant Chemotherapy Followed by Goserelin Versus Either Modality Alone for Premenopausal Lymph Node-Negative Breast Cancer: A Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- Tailoring adjuvant treatments for the individual breast cancer patientThe Breast, 2003
- Survival analyses from the ZEBRA studyEuropean Journal Of Cancer, 2003
- Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results DatabaseBreast Cancer Research and Treatment, 2002
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978